Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • Neurodegeneration (Mar 2026)
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Challenges to achieving clinical transplantation tolerance
Alan D. Salama, Giuseppe Remuzzi, William E. Harmon, Mohamed H. Sayegh
Alan D. Salama, Giuseppe Remuzzi, William E. Harmon, Mohamed H. Sayegh
View: Text | PDF
Spotlight

Challenges to achieving clinical transplantation tolerance

  • Text
  • PDF
Abstract

Authors

Alan D. Salama, Giuseppe Remuzzi, William E. Harmon, Mohamed H. Sayegh

×

Figure 1

Options: View larger image (or click on image) Download as PowerPoint
The fate of alloreactive T cells. Upon antigen engagement and in the pre...
The fate of alloreactive T cells. Upon antigen engagement and in the presence of adequate costimulatory signals, the alloreactive T cell becomes activated, proliferates, and is subject to a number of different fates. The first is differentiation to an effector cell, orchestrating the immune response directed toward the target antigen. Some of the T cells will differentiate into memory cells, able to provide rapid recall responses upon antigenic restimulation. Other cells will have their effector functions terminated either by anergy or by apoptotic death (which may be passive or may involve activation-induced cell death [AICD]), or as a consequence of regulation by other cells or soluble factors. CTL, cytotoxic T lymphocyte; DTH, delayed-type hypersensitivity.

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts